Achiko
Achiko creates and develops new innovations in healthcare diagnostics and technology.
Achiko operates in digital health based in Indonesia, founded in 2018.
Profile
Achiko has created user-friendly diagnostic testing integrated with a digital passport solution for the management of COVID-19. AptameX™ includes DNA aptamer-based technology that is cost effective, chemically synthesised, and widely applicable to the evolving diagnostic field of healthcare. Together with the digital mobile health app Teman Sehat™, Achiko is developing potential technologies that seek to deliver rapid, affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications. AptameX™ and Teman Sehat™ were launched in Indonesia in mid-2021 and AptameX™ received the CE Mark in the European Union in May 2022.
As a business in digital health, Achiko is listed here with the public details available about it.
Indonesia is where the company is located.
It is recorded at the SOSV portfolio company stage.
Recorded headcount: 11-50 employees.
Public records show total funding of about $15K.
| Sector | Digital Health |
|---|---|
| Country | Indonesia |
| Founded | 2018 |
| Employees | 11-50 |
| Stage | SOSV portfolio company |
| Total funding | $150,000 |
Website: achiko.com
Create a free account